In his first major action on health care costs this term, President Donald Trump issued a multi-part executive order on ...

Exiger warns the U.S. is overly reliant on foreign countries to make key components of crucial medications as the Trump ...

The US president vows "major" tariffs on imported medicines - raising fears of an increase in costs for Americans.

However, it's possible that other drugmakers could be more interested in teaming up with Recursion with the FDA promoting the ...

在科技飞速进步的今天，人工智能（AI）正在悄然改变各个领域，尤其是在医药研发方面。最近，Recursion Pharmaceuticals（RXRX.US）等AI医药开发概念股的股价大幅上涨，吸引了投资者的目光。根据智通财经APP的报道，Recursion Pharmaceuticals的股价上涨近23%，而Certara（CERT.US）和Simulations ...

MIRA Pharmaceuticals (MIRA) announced data demonstrating the efficacy of the oral ketamine analog, Ketamir-2, in a validated animal model of ...

The Trump administration has taken its next steps toward imposing more tariffs on key imports, launching investigations into ...

Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on Apellis Pharmaceuticals (APLS – Research Report) today and set a ...